Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer

Immunotherapy has revolutionized the treatment of metastatic non-small cell lung cancer (NSCLC). Oligometastasis has been associated with better prognosis than widespread metastatic disease and may be curable by stereotactic body radiotherapy (SBRT). SBRT can stimulate immunogenic anti-tumor activit...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaoli, Chi, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511897/
https://www.ncbi.nlm.nih.gov/pubmed/37746276
http://dx.doi.org/10.3389/fonc.2023.1211815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511897/
https://www.ncbi.nlm.nih.gov/pubmed/37746276
http://dx.doi.org/10.3389/fonc.2023.1211815

Ejemplares similares